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In	 patients	 with	 coronary	 artery	 disease	 (CAD),	 multi-parametric	 cardiovascular	
magnetic	 resonance	 (CMR)	 provides	 detailed	 information	 about	 the	 myocardial	
tissue	composition	and	its	function.	This	thesis	aims	to	investigate	how	myocardial	




We	 have	 prospectively	 recruited	 and	 conducted	 multi-parametric	 CMR	 in	 76	




presence	 of	 microvascular	 obstruction	 (MVO)	 or	 intramyocardial	 haemorrhage	
(IMH)	 in	 STEMI	patients.	 Study	1	demonstrated	 the	diagnostic	 accuracy	of	mitral	
annular	 plane	 systolic	 excursion	 (MAPSE)	 to	 detect	 MVO/IMH.	 Study	 2	
demonstrated	that	peak	global	longitudinal	strain	(GLS)	is	most	strongly	associated	
with	MVO/IMH	when	compared	to	other	myocardial	deformation	parameters.	Study	
3	 demonstrated	 that	 during	 first-pass	 perfusion	 stress	 CMR,	 at	 peak	 hyperemic	
stress,	 GLS	 is	 reduced	 in	 the	 presence	 of	 a	 perfusion	 defect	 in	 patients	 being	











































































































































































































































































































































































































1	 Computed	 tomography	 coronary	 angiography;	 2	 Myocardial	 contrast	
echocardiography	 for	 the	 assessment	 of	 perfusion	 defects;	 3	 Rest	 myocardial	
perfusion	 scintigraphy;	4	Contrast	enhanced	magnetic	 resonance	angiography	 for	
detection	 of	 proximal	 coronary	 anomaly;	 5	 Stress	 cardiac	magnetic	 resonance;	 6	
Myocardial	 ischaemic	memory	 imaging	with	β-methyl-p-iodophenylpentadecanoic	
acid;	 7	 Strain	 imaging	 on	 echocardiography	 for	 heterogeneity	 of	 strain	 curves;	 8		
Myocardial	tagging	with	cardiac	magnetic	resonance	for	regional	strain	variations	in	
ischaemic	 myocardium;	 9	 Echocardiography	 to	 detect	 regional	 wall	 motion	
abnormality;	10	Cine	cardiac	magnetic	 resonance	 imaging	 to	detect	 regional	wall	
motion	 abnormality;	 11	 Ratio	 of	 peak	mitral	 inflow	 velocity	 (E)	 and	mitral	 valve	
propagation	velocity	(Vp)	for	estimating	LA	pressure	(E/Vp);	12	Native	T1-Maps	on	
cardiac	magnetic	 resonance	 imaging	 for	quantification	of	myocardial	oedema;	13	
T2-weighted	cardiac	magnetic	resonance	imaging	for	myocardial	oedema;	14	Late	
gadolinium	 enhancement	 imaging	 on	 cardiac	 magnetic	 resonance	 for	 scarred	
myocardium;	 15	 late	 gadolinium	 enhancement	 (LGE)	 imaging	 for	 microvascular	
obstruction;	 16	 T2*-imaging	 on	 cardiac	magnetic	 resonance	 for	 intra-myocardial	
haemorrhage.		
1.1 Established	role	of	CMR	in	the	assessment	of	ACS		
Cardiac	Magnetic	 Resonance	 (CMR)	 has	 an	 emerging	 role	 in	 the	 assessment	 and	
management	of	patients	with	ACS,	 in	particular	 those	who	are	clinically	stable.	 It	







where	 available,	 may	 be	 appropriate	 to	 detect	 coronary	 anomalies.	 Current	
European	Society	of	Cardiology	(ESC)	guidelines	highlight	in	particular	the	ability	of	
CMR	to	detect	myocarditis,	assess	viability	and	perfusion	defects	in	suspected	ACS	
























within	 3	 days	 of	 the	 acute	 event	 had	 sensitivity	 96%	 and	 specificity	 83%	 for	
significant	CAD	defined	by	invasive	angiography.	It	was	also	more	accurate	than	the	
Thrombolysis	in	Myocardial	Infarction	(TIMI)	risk	score	(P<0.001).	In	a	study	of	161	





only	 84%	 and	 85%,	 respectively,	 CMR	 added	 incremental	 value	 over	 clinical	
parameters.	 A	 study	 of	 135	 low-risk	 patients	 presenting	 to	 the	 emergency	
department	with	chest	pain	showed	that	no	patients	with	a	normal	adenosine	CMR	
study	had	 a	 subsequent	 diagnosis	 of	 CAD	or	 an	 adverse	outcome	after	 one	 year	
(Ingkanisorn	et	al.,	2006).	In	the	same	study,	the	sensitivity	of	stress-CMR	was	100%	
with	a	specificity	of	93%	for	predicting	adverse	outcomes	during	a	one-year	follow-
up	 period.	 In	 two	 similar	 separate	 studies	 evaluating	 192	 patients	who	 received	
adenosine	stress	and	rest	CMR,	none	of	the	patients	with	normal	CMR	had	clinical	
events	 during	 9-months	 of	 follow-up	 (Lerakis	 et	 al.,	 2009;	 Hartlage	 et	 al.,	 2012).	






A	 typical	 CMR	 study	 takes	 between	 30	 and	 60	minutes	 and	 typically	 includes	 T1	











The	 basic	 principles	 of	 CMR	 assessment	 of	 cardiac	 structure,	 function	 and	 tissue	















shortened	 close	 to	 real-time	 with	 acceleration	 techniques	 (such	 as	 sensitivity	





are	 drawn	 at	 end-systole	 and	 end-diastole.	 As	 the	 slice	 thickness	 is	 known,	 the	
volume	of	each	disc	can	be	calculated	and	by	adding	the	volumes	of	each	slice	end-










Measurement	 of	 EF	 by	 CMR	 inform	 diagnosis	 and	 prognosis.	 The	 degree	 of	 LV	
impairment	is	associated	with	adverse	outcomes	and	increased	mortality	(Gradman	






summation	 of	 discs	 method	 described	 previously.	 In	 patients	 with	 previous	
myocardial	 infarction	 (MI),	 RV	 EF	 <40%	 was	 associated	 with	 adverse	 outcomes	
independently	of	other	 factors	 including	 LV	EF	 (Larose	et	 al.,	 2007).	 Impaired	RV	
function	is	associated	with	adverse	outcomes	in	diseases	that	primarily	affect	the	RV	
such	 as	 pulmonary	 arterial	 hypertension	 and	 arrhythmogenic	 right	 ventricular	







mortality	 (Frangogiannis,	 2006).	 Animal	 studies	 have	 revealed	 that	 post-infarct	
remodeling	 is	 the	 consequence	 of	 an	 interplay	 between	 numerous	 mechanical,	
neuro-hormonal,	 microvascular,	 and	 macrovascular	 factors	 (Sutton	 and	 Sharpe,	













of	 left	 ventricular	 function.	 However,	 this	 method	 doesn’t	 inform	 us	 about	
‘myocardial’	 regional	 or	 global	 function	 and	 is	 extremely	 sensitive	 to	 loading	
conditions.	 Importantly,	 in	 several	 cardiomyopathies	 including	 hypertrophic	
cardiomyopathy,	the	EF	remains	preserved	and	if	anything,	the	EF	increases	in	mild	
to	moderate	 concentric	 hypertrophy.	 However,	 in	 these	 patients	 left	 ventricular	
longitudinal	 function	 is	 markedly	 reduced	 (Young	 et	 al.,	 1994).	 Hence	 these	













Feature	 tracking	 is	 a	 new	post	 processing	 technique	which	 allows	 for	 tracking	of	













Abrupt	 occlusion	 of	 coronary	 artery	 results	 in	 initiation	 of	 several	 structural,	
metabolic	 and	 functional	 pathways	 within	 the	 subtended	 myocardium	 which	
eventually	 results	 in	 myocardial	 necrosis.	 Necrosis	 is	 initiated	 from	 the	 sub-
endocardium	 to	 the	 epicardium	 in	 a	 wave-front	 manner	 (Reimer	 and	 Jennings,	
1979).	Myocardial	 oedema	 develops	 before	 ischaemic	 necrosis	 or	 even	 troponin	
release	 (Abdel-Aty	 et	 al.,	 2009)	 and	 can	 persist	 even	 when	 ECG	 changes	 and	
myocardial	dysfunction	have	resolved	(h-Ici	et	al.,	2014)	(Figure	1.1).	Post	ischaemic	
injury,	myocardial	oedema	can	persist	up	to	six	month	(Dall’Armellina	et	al.,	2011).		
In	 CMR	 study,	 T2-weighted	 imaging	 (T2W-imaging)	 is	 the	 standard	 imaging	
technique	 for	 detecting	 acute	myocardial	 edema.	 It	 is	 used	 for	 differentiation	 of	
acute	from	chronic	MI	(Abdel-Aty	et	al.,	2004),	assessment	of	the	area	at	risk	(AAR)	





techniques.	 T1-mapping	 can	 quantify	 the	 extent	 and	 severity	 of	 acute	 ischaemic	
injury.	 In	 an	 early	 study,	 non-contrast	 T1-maps	 had	 96%	 sensitivity	 and	 91%	
specificity	for	detecting	acute	MI	(Messroghli	et	al.,	2007).		In	a	more	recent	study,	
T1-mapping	was	 superior	 to	T2W-imaging	 in	detecting	non-ST-elevation	MI	 (area	
under	the	curve	0.91	±	0.02	versus	0.81	±	0.04,	respectively	P=0.004)	(Dall’Armellina	
et	al.,	2012).	T1-mapping	is	also	superior	to	T2W	and	LGE-imaging	in	detecting	acute	
myocarditis,	 which	 is	 one	 of	 the	 key	 differential	 diagnoses	 in	 acute	 chest	 pain	
patients	(Ferreira	et	al.,	2013;	Garg,	John	P	J.P.	Greenwood	and	Plein,	2015).		
Post	ACS,	area	at	risk	(AAR)	is	defined	as	total	area	of	the	myocardium	subtended	by	





whole	area	potentially	can	necrose	resulting	 into	permanent	 transmural	 scar	and	















myocardium	 as	 bright	 when	 compared	 to	 the	 reference.	 The	 pattern	 of	 hyper-
enhancement	 on	 LGE	 can	 aid	 in	 the	 diagnosis	 of	 the	 aetiology	 of	 many	 cardiac	
pathologies.	 For	 example,	 sub-endocardial	 or	 transmural	 LGE	 is	 seen	 in	 ischemic	
cardiomyopathy,	 mid	 wall	 LGE	 in	 dilated	 and	 hypertrophic	 cardiomyopathies,	
epicardial	LGE	in	myocarditis	and	global	diffuse	sub-endocardial	LGE	in	amyloidosis.	
The	presence	of	hyper-enhancement	on	LGE	imaging	is	shown	to	match	well	with	
discrete	 fibrosis	 on	 histology	 and	 is	 associated	 with	 adverse	 prognosis	 in	 many	
cardiomyopathies	(Ismail	et	al.,	2012).	
Post	myocardial	infarction,	LGE	imaging	plays	an	important	role	in	defining	infarct	
size	 (IS)	 and	 the	 assessment	 of	 viability	 in	 the	 infarcted	 segments	 (Kwong	 and	









or	 FWHM	 thresholding	methods	 have	 been	 shown	 to	 provide	 reliable	 results	 of	




Microvascular	 obstruction	 (MVO)	 occurs	 post	 ST-elevation	 myocardial	 infarction	
(STEMI)	 in	 a	 certain	 group	 of	 patients	 who	 receive	 reperfusion	 therapy	 after	
prolonged	myocardial	 ischaemia	(Moens	et	al.,	2005).	 It	has	been	associated	with	
‘no-reflow’	 on	 invasive	 coronary	 angiogram	 in	 the	 culprit	 vessel.	 No-reflow	 is	




of	 embolic	 debris,	 consisting	 of	 atherosclerotic	 plaque	 components	 and/or	
thrombotic	material.	 Distal	 embolization	may	 not	 only	 contribute	 to	mechanical	
obstruction	of	the	micro-vessels	but	also	causes	an	inflammatory	response	with	the	
elaboration	of	vasogenic	and	thrombogenic	factors	that	further	exacerbate	existing	
microvascular	 dysfunction.	 Therefore,	 patho-physiologically,	MVO	 is	 the	 result	 of	
the	complex	interplay	of	a	number	of	related	processes.		
Reperfusion	may	also	lead	to	intramyocardial	haemorrhage	(IMH)	in	the	infarct	core	
(Roberts	 et	 al.,	 1983)	 via	 extravasation	 of	 blood	 through	 damaged	 endothelium	
(Basso	and	Thiene,	2006).	Both	MVO	and	IMH	are	gradually	being	recognized	as	a	
poor	 prognostic	 marker	 and	 an	 indicator	 of	 subsequent	 adverse	 LV	 remodeling,	
independently	of	IS	(Morishima	et	al.,	2000;	Wu	et	al.,	1998;	Mather	et	al.,	2011).  
In	pre-clinical	and	human	studies	post-acute	reperfused	infarction	(Judd	et	al.,	1995;	
Lima	 et	 al.,	 1995),	 regions	 of	 myocardial	 hypo-enhancement	 within	 the	 first	 2	
minutes	 of	 contrast	 administration	were	 observed	within	 the	 infarct	 region	 that	










assessed	 by	 combined	 analysis	 of	 T2W	and	 T2*	 images	 (Figure	 1.3).	 IMH	 can	 be	





















imaging	 demonstrates	 hyper-enhancement	 in	 the	 inferio-lateral	 segments	with	 a	
dark	core	within	it.	LGE	imaging	demonstrates	extensive	inferio-lateral	myocardial	











urgent	 reperfusion	 therapy,	 the	 incidence	 is	 around	 5-7%.	 Early	 gadolinium	
enhancement	 (EGE)	 imaging	 is	 superior	 to	 transthoracic/transesophageal	
echocardiography	 for	 the	 detection	 of	 LV	 thrombus	 (Mollet	 et	 al.,	 2002).	 EGE	
imaging	 is	 done	 immediately	 post	 contrast	 administration	 in	 multiple	 planes	 to	
detect	the	presence	of	LV	thrombus		(Goyal	and	Weinsaft,	2013).	On	EGE	imaging,	





failure.	 As	 described	 in	 the	 preceding	 section,	 LGE	 imaging	 is	 a	 well-established	
method	 to	 assess	 and	 quantify	 the	 size	 and	 transmurality	 of	 discrete	 areas	 of	
fibrosis/infarction.	However,	this	process	relies	on	nulling	the	healthy	myocardium	
and	 on	 comparing	 the	 enhancement	 of	 healthy	 and	 diseased	 myocardium	
qualitatively.	When	 the	myocardium	 is	 more	 diffusely	 diseased,	 techniques	 that	





for	 tissue	 characterization	 or	 can	 be	 combined	 with	 post	 contrast	 acquisitions.	
Native	 (non-contrast)	 T1-maps	 can	 detect	 pathology	 related	 to	 excess	 water	 in	
oedema,	protein	deposition,	changes	in	lipid/iron	content	in	the	myocardium	(Moon	
et	 al.,	 2013).	 However,	 native	 T1-maps	 do	 not	 inform	 us	 about	 the	 intra-/extra-	
cellular	composition	of	the	myocardium.	Additionally,	even	though	quantification	of	







an	 expanded	 extracellular	 space	 due	 to	 fibrosis,	 infiltration	 or	 scar	 have	 a	 larger	





Post	 contrast	 T1	 mapping	 makes	 assumptions	 about	 the	 kinetics	 of	 gadolinium	
contrast	agents	and	the	results	can	be	influenced	by	renal	function,	haematocrit	and	
body	 composition.	 These	 assumptions	 can	be	overcome	by	 combining	pre-/post-
contrast	T1	mapping	of	both	myocardium	and	blood	and	correcting	for	the	blood	
volume	of	distribution	(1-haematocrit).	From	these	data,	maps	of	the	extracellular	
volume	 (ECV)	 fraction	 can	 be	 calculated	 which	 show	 significant	 correlation	 with	
histological	degree	of	fibrosis	and	volume	of	collagen	in	the	myocardium	(Flett	et	al.,	
2010).	ECV	is	calculated	using	the	formula:	
	𝐸𝐶𝑉 = 1 − 𝐻𝑐𝑡 *+ ,-.	012 3*+(,-.	0.56)*+ 89..:	012 3*+(89..:	0.56)						 where	R1=1/T1	
	
ECV	 is	 a	 promising	 measure	 of	 extracellular	 matrix	 (ECM)	 expansion,	 which	 is	
adversely	 related	 to	 mechanical,	 electrical	 and	 vasomotor	 dysfunction	 of	 the	
myocardium	 (Moon	 et	 al.,	 2013).	 Increased	 ECV	 have	 been	 reported	 in	 several	
cardiomyopathies	including	amyloidosis,	dilated	cardiomyopathy	and	hypertrophic	
cardiomyopathy	(Dass	et	al.,	2012;	Puntmann	et	al.,	2013;	Sado	et	al.,	2012).	Hence,	
ECV-maps	 add	 incremental	 diagnostic	 value	 to	 quantify	 global/focal	 myocardial	
fibrosis,	which	is	mainly	a	process	in	the	ECM.	ECV	values	are	independent	of	the	
field	strength	of	the	CMR	scanners.		
In	 a	 recent	 study	 of	 1172	 subjects,	 Schelbert	 and	 Wong	 demonstrated	 that	


































pulse-wave	 Doppler	 echocardiography	 (DE)	 technique.	 However,	 DE	 has	 several	
limitations	 due	 to	 2D-planar	 assessment,	 through-plane	motion,	 high	 intra-inter-
operator	variability	and	a	recent	meta-analysis	queries	the	diagnostic	accuracy	of	

















Myocardial	 deformation	 analysis	 using	 CMR	 feature	 tracking	 offers	 mechanistic	
insights	 into	 regional	 myocardial	 function.	 Additionally,	 it	 can	 discriminate	 and	
quantify	 the	 function	of	 the	 three	main	different	 types	of	myofiber	orientations:	
longitudinal,	 circumferential	 and	 radial	 orientation.	 In	 patients	with	 ACS	 or	 CAD,	
there	remains	limited	understanding	on	how	the	presence	of	MVO,	IMH	or	perfusion	
defect	 on	 first-pass	 perfusion	 CMR	 influences	 the	 function	 of	 the	 three	 main	
myofiber	 orientations	 or	 myocardial	 deformation.	 Alteration	 in	 myocardial	
deformation	 could	 potentially	 be	 used	 clinically	 or	 as	 a	 surrogate	 end-point	 in	
research	across	other	imaging	modalities.		
Quantification	of	ECV	in	acute	infarct	patients	seems	to	add	incremental	information	
above	 LGE-imaging.	 Moreover,	 LGE	 imaging	 overestimates	 acute	 infarct	 size.	








Study	 2:	 To	 investigate	 the	 association	 of	 MVO,	 IMH	 and	 convalescent	 left	


































For	 chapter	 4,	 age	 and	 sex	matched	healthy	 volunteers	 serving	 as	 controls	were	














































Short-axis	 LV	 cine	 stack:	 Resting	 wall	 motion	 and	 left	 ventricular	 function	 were	
assessed	with	a	contiguous	stack	of	multiphase	ventricular	short-axis	bSSFP	cines	







































LGE-imaging	was	performed	10-15	minutes	after	 the	bolus	contrast	 injection	 (0.1	
mmol/kg	gadolinium-DTPA:	gadopentetate	dimeglumine;	Magnevist,	Bayer,	Berlin,	
Germany)	was	then	administered	using	a	power	injector	(Spectris,	Solaris,	PA).using	






































Images	 were	 evaluated	 offline	 using	 the	 following	 software’s:		
1)	Commercially	available	software	(cvi42	v4.1.5,	Circle	Cardiovascular	Imaging	Inc.,	
Calgary,	Canada):	Chapter	3,4	and	5.	2)	In-house	research	software	developed	with	





LV	 end	 systolic	 and	 end	 diastolic	 volumes	 according	 to	 the	 summation	 of	 discs	
methodology	(Vogel-Claussen	et	al.,	2006).	 	LV	ejection	fraction	was	derived	from	
the	 equation:	 LVEF	 (%)	 =	 ((LVEDV-LVESV)/LVEDV)	 x	 100.	 	 Both	 trabeculation	 and	
papillary	muscles	were	 excluded.	 	 LV	mass	 values	were	 calculated	 from	 the	 end	





range,	 IQR)	 or	 frequency	 (percentage).	 Data	were	 tested	 for	 normality	 using	 the	
Shapiro-Wilks	test.	 	For	normally	distributed	data,	two-tailed	unpaired	Student’s	t	
tests	were	used	for	comparisons	between	groups,	and	paired	Students	t	tests	were	












Based	 on	 the	 published	 data	 (Bellenger	 et	 al.,	 2000),	 the	 group	 size	 required	 to	
detect	a	10ml	change	in	LVEDV	is	12	patients,	10	patients	to	detect	a	10ml	change	
in	LVESV,	15	to	detect	a	3%	change	in	LVEF	and	9	to	detect	a	10g	change	in	LV	mass.	
Therefore,	 on	 the	 assumption	 that	 around	 25%	 patient	 post-STEMI	 will	 develop	
adverse	 LV	 remodelling,	 we	 need	 to	 recruit	 a	 minimum	 of	 40-44	 patients,	 to	
investigate	adverse	remodelling	in	chapter	3,4	and	6.	Chapter	5	and	7	were	mainly	










3 		Study	 1-	 Ventricular	 Longitudinal	 Function	 is	




Microvascular	 obstruction	 (MVO)	 and	 intramyocardial	 haemorrhage	 (IMH)	 are	
associated	with	adverse	prognosis,	independently	of	infarct	size	after	reperfused	ST-
elevation	 myocardial	 infarction	 (STEMI).	 Mitral	 annular	 plane	 systolic	 excursion	
(MAPSE)	 is	 a	 well-established	 parameter	 of	 longitudinal	 function	 on	
echocardiography.	We	 aimed	 to	 investigate	 how	 acute	MAPSE,	 assessed	 by	 a	 4-






were	 measured	 from	 LGE	 images.	 The	 presence	 of	 IMH	 was	 investigated	 by	





were	 associated	 with	 lower	 averaged-MAPSE	 (11.7±0.4mm	 versus	 9.3±0.3mm;	
p<0.001	and	11.8±0.4mm	versus	9.2±0.3mm;	p<0.001,	respectively).	IMH	(beta=-







and	92%	sensitivity	and	74%	specificity	 for	 IMH.	LV	remodelling	 in	convalescence	
was	not	associated	with	MAPSE	(AUC	0.62,	95%	CI	0.44-0.77,	p=0.22).		
3.1.4 Conclusions	








Following	 reperfused	 acute	 myocardial	 infarction	 (AMI),	 the	 left	 ventricle	 (LV)	
undergoes	 structural	 adaptations	 both	 within	 and	 outside	 of	 the	 infarct	 zone,	
referred	 to	 as	 LV	 remodelling.	 In	 approximately	 50%	 of	 patients,	 coronary	
reperfusion	is	associated	with	microvascular	obstruction	(MVO)	(Moens	et	al.,	2005).	
Reperfusion	may	also	lead	to	intramyocardial	haemorrhage	(IMH)	in	the	infarct	core	






1995).	 Similarly,	 MVO	 and	 IMH	 predominantly	 affect	 the	 subendocardial	 layer.	
Endocardial	fibres	are	structurally	longitudinal	fibres	(Greenbaum	et	al.,	1981)	and	








Figure	 3.1	 Illustration	 of	 orientation	 of	 myocardial	 fibres	 with	 corresponding	
representation	of	infarct	related	zones.	
	











We	sought	 to	 investigate	 the	effect	of	MVO	and	 IMH	on	MAPSE	 in	patients	with	






















and	 planimetered	 manually.	 Volumes	 of	 infarct	 and	 MVO	 were	 calculated	 from	
planimetered	areas	across	the	whole	LV	stack	by	the	modified	Simpson’s	method.	
The	presence	 and	extent	 of	myocardial	 haemorrhage	was	 assessed	by	 combined	
analysis	 of	 T2w	 and	 T2*	 sequences	 [8].	 On	 T2w	 images,	 areas	with	mean	 signal	
intensity	 more	 than	 2	 SD	 below	 the	 periphery	 of	 the	 area	 at	 risk	 (AAR)	 were	
considered	to	represent	haemorrhage	(Kidambi,	Adam	N	Mather,	et	al.,	2013).	On	












































For	 MAPSE,	 three	 parameters	 were	 assessed	 –	 septal	 wall	 MAPSE;	 lateral	 wall	








patients	 were	 divided	 into	 2	 groups	 based	 on	 the	 presence	 of	 LV	 remodelling,	
defined	 by	 the	 following:	 a)	 an	 increase	 of	 LV	 end-diastolic	 volume	 >	 20%	 at	 3	
months’	 follow-up	 scan	 or	 b)	 as	 increase	 of	 LV	 end-systolic	 volume	 >	 20%	 at	 3	
months’	follow-up	scan.	
3.3.3 Statistical	analysis	
Multivariate	 linear	 regression	 was	 used	 for	 variables	 with	 statistical	 significance	
from	 univariate	 analysis	 (p<0.1).	 The	 accuracy	 of	 averaged-MAPSE	 in	 predicting	










































The	mean	 ejection	 fraction	 of	 the	 study	 cohort	was	 48±10%,	 septal	MAPSE	was	
9.6±2.9mm,	lateral	MAPSE	11±2.3mm	and	averaged	MAPSE	of	10.3±2.1mm	(Table	
3.2).	
Twenty-six	 (59%)	patients	had	MVO	and	25	 (57%)	had	 IMH.	No	patient	had	 IMH	
without	MVO.	Averaged	MAPSE	for	patients	with	MVO	was	significantly	lower	than	
for	patients	without	MVO	(9.3±0.3mm	versus	11.7±0.4mm;	p<0.001).	Similarly,	 in	



























































































Diabetes	Mellitus	 0.002	 0.006	 0.60	 	 0.01	 0.05	
Age	 0.36	 	 0.11	 	 0.13	 	
CK	 0.26	 	 0.72	 	 0.33	 	
Pain-Balloon	Time	 0.0	 0.004	 0.26	 	 0.45	 	
Sex	 0.27	 	 0.44	 	 0.74	 	
Smoking	History	 0.79	 	 0.86	 	 0.77	 	
Hypertension	 0.64	 	 0.65	 	 0.94	 	
















IMH	 <0.01	 <0.01	 <0.01	 <0.01	 <0.01	
(-0.65)	
<0.001	
Ejection	Fraction	 0.02	 0.246	 0.09	 0.82	 0.01	 0.293	
SVi	 0.06	 0.187	 0.27	 	 0.06	 0.207	
Infarct	Volume	 0.69	 	 0.23	 	 0.35	 	
Infarct	Mass	 0.11	 	 0.49	 	 0.48	 	
Anterior	Infarct	 0.33	 	 0.91	 	 0.54	 	
LVEDVi	 0.95	 	 0.97	 	 0.98	 	
	 Abbreviations:	UN,	univariate;	MV,	multivariate	









up	 scans.	 All	 38	 patients	 scans	 were	 of	 good	 quality	 and	 could	 be	 analysed.	 All	
patients	had	complete	resolution	of	MVO	and	IMH	on	90-day	scans.	Infarct	volume	
reduced	 from	 14.1±11.8mls	 at	 baseline	 to	 8.2±6.7mls	 (p<0.001)	 at	 follow	 up.	 As	
compared	to	baseline,	EF	improved	by	21±22%	and	averaged-MAPSE	improved	by	
28±22%	(p<0.001	for	each).	On	linear	regression	analysis	taking	into	account	day-2	






On	 intra	 observer	 analysis,	 the	 means	 of	 septal	 MAPSE	 (8.52±2.2mm	 versus	
8.54±2.1mm;	 p=0.87,	 CoV	 4%),	 lateral	MAPSE	 (9.97±2.2mm	 versus	 9.99±1.9mm;	
p=0.92,	CoV	5.9%)	and	septal	MAPSE	(9.24±1.8mm	versus	9.27±1.8mm;	p=0.88,	CoV	
4.1%)	were	similar.		













MAPSE	 is	 a	 well-established	 and	 endorsed	 parameter	 of	 global	 LV	 longitudinal	
function	in	echocardiography.	A	lower	absolute	value	of	MAPSE	in	post	AMI	is	a	poor	
prognostic	 marker	 (Hu	 et	 al.,	 2013).	 Previous	 studies	 using	 speckle	 tracking	
echocardiography	 in	 AMI	 patients	 have	 shown	 that	 MVO	 determined	 on	 CMR	
adversely	affects	global	longitudinal	strain	(GLS)	on	echocardiography	(Bergerot	et	
al.,	 2014;	 Bière	 et	 al.,	 2014).	 However,	 with	 current	 technology,	 there	 remains	
marked	variability	in	GLS	depending	on	the	measurement	algorithms	on	the	vendor’s	
software	and	also	on	the	sample	volume	definition.	Therefore,	no	specific	vendor	
independent	 normal	 ranges	 are	 provided	 in	 current	 American	 and	 European	
guidelines	 (Thomas	 and	 Badano,	 2013).	 MAPSE,	 on	 the	 contrary,	 is	 a	 vendor	
independent	parameter	of	global	longitudinal	function,	which	can	also	be	measured	
from	standard	cine	CMR	images	[18,33].	Limited	data	are	available	in	the	literature	
on	 the	 association	 of	MAPSE	 assessed	 by	 CMR	 to	microvascular	 obstruction	 and	
none	for	IMH.	This	study	demonstrated	that	reduced	averaged-MAPSE	is	associated	
the	presence	of	MVO/IMH.		




comparing	 tagging	 to	 FT-derived	 strain,	 FT-derived	 strain	was	quicker	 to	 analyse,	
tracked	 myocardium	 better,	 had	 better	 inter-observer	 variability	 and	 stronger	
correlations	with	 infarct	and	oedema	 (Khan	et	al.,	 2015).	 Furthermore,	 similar	 to	












volume	 of	 the	 left	 ventricle	 versus	 circumferential	 fibres	 which	 contribute	 43%	
(Maciver,	 2012).	 Hence,	 even	 though	MAPSE	may	 be	more	 adversely	 affected	 in	
patients	with	MVO	or	IMH,	MAPSE	does	not	necessarily	result	in	LV	remodelling.	LV	
remodelling	is	directly	proportional	to	the	infarct	transmural	extent	and	hence	more	
related	 to	 strain	 parameters,	 which	 involve	more	mid,	 and	 epicardial	 fibres,	 for	
example,	circumferential	strain.			
3.5.1 Clinical	Implications	




STEMI.	 MVO	 and	 IMH	 are	 independent	 histo-pathological	 and	 cardiac	 imaging	
markers	of	adverse	prognosis	and	their	early	detection	from	routinely	acquired	CMR	
images	 by	 MAPSE	 may	 help	 tailor	 appropriate	 pharmacological	 interventions.	
Patients	with	previous	history	of	allergy	 to	gadolinium-based	contrast	or	patients	
with	 end-stage	 renal	 failure	may	 also	 benefit	 from	 this	 technique	 to	 predict	 the	
likelihood	of	presence	of	MVO	or	IMH.	MAPSE	can	also	be	evaluated	by	bedside	M-
Mode	 echocardiography	 in	 post	 infarct	 patients	 and	 it	 could	 potentially	 act	 as	 a	
gatekeeper	for	further	assessment	by	CMR.		
3.5.2 Study	limitations	










possible	 to	 investigate	 whether	 there	 remains	 an	 incremental	 value	 of	 using	
averaged-MAPSE	 for	 the	detection	of	 IMH.	Additionally,	 the	absolute	measure	of	
MAPSE	does	not	take	the	total	length	of	the	LV	into	account,	which	is	potentially	a	




















In	 the	 setting	of	 STEMI,	 it	 remains	unclear	which	 strain	parameter	most	 strongly	
correlates	 with	 MVO	 or	 IMH.	 	 Therefore,	 the	 objective	 of	 this	 study	 was	 to	
investigate	 the	 association	 of	 MVO,	 IMH	 and	 convalescent	 left	 ventricular	 (LV)	




following	 reperfused	 STEMI.	 10	 age	 and	 gender	 matched	 healthy	 controls	 were	
recruited	and	received	baseline	CMR	only.	Cine,	T2-weighted,	T2*-imaging	and	late	
gadolinium	enhancement	(LGE)	imaging	were	performed.	Infarct	size,	MVO	and	IMH	
were	 quantified.	 Peak	 global	 longitudinal	 strain	 (GLS),	 global	 radial	 strain	 (GRS),	
global	 circumferential	 strain	 (GCS)	 and	 their	 strain	 rates	were	derived	by	 feature	
tracking	analysis	of	LV	short-axis,	4-chamber	and	2-chamber	cines.		
4.1.3 Results		
All	 43	 patients	 and	 10	 controls	 completed	 the	 baseline	 scan	 and	 34	 patients	
completed	 3-month	 scans.	 In	 multivariate	 regression,	 GLS	 demonstrated	 the	
strongest	association	with	MVO	or	 IMH	(beta=0.53,	P<0.001).	The	optimal	cut-off	
value	 for	GLS	was	 -13.7%	 for	 the	 detection	 of	MVO	or	 IMH	 (sensitivity	 76%	 and	
specificity	 77.8%).	 At	 follow	 up,	 17%	 (n=6)	 patients	 had	 adverse	 LV	 remodeling	






















with	 MVO	 and	 is	 caused	 by	 endothelial	 dysfunction	 following	 prolonged	
ischaemia/reperfusion	 injury	 with	 disruption	 of	 inter-endothelial	 junctions	 and	
extravasation	of	erythrocytes	(Betgem	et	al.,	2015).		
Myocardial	 systolic	 function	after	STEMI	 is	 conventionally	assessed	by	calculating	
left	 ventricular	 ejection	 fraction	 (EF)	 from	 left	 ventricular	 volumes	 (Burns	 et	 al.,	
2002;	 Gibbons	 et	 al.,	 2004;	 Møller	 et	 al.,	 2006).	 However,	 global	 EF	 is	 load-




1981).	 Emerging	 technologies	 have	 made	 it	 possible	 to	 study	 myocardial	
deformation	 by	 CMR	 using	myocardial	 tagging	 and	 feature	 tracking	 (FT)	 derived	
strain	 (Hor	et	al.,	2011;	 Ibrahim,	2011).	Strain	 (S)	and	strain	 rate	 (SR)	are	already	
established	 as	 more	 accurate	 measures	 of	 both	 regional	 and	 the	 global	 left	
ventricular	 function	 when	 compared	 to	 ejection	 fraction	 and	 allow	 quantitative	
assessment	 of	 myocardial	 deformation	 (Shah	 and	 Solomon,	 2012).	 From	 strain	
analysis,	several	parameters	can	be	derived	and	it	is	currently	not	known	which	of	



















acquiring	 the	 central	 3	 slices	 (base,	mid	 and	 apical)	 of	 5	 parallel	 short-axis	 slices	
(Messroghli	et	al.,	2005).		
4.3.3 CMR	interpretation	
Cine,	 T2w,	 T2*	 and	 LGE	 images	 were	 evaluated	 offline.	 Infarct	 location	 was	
determined	 by	 LGE	 imaging,	 according	 to	 standard	 guidelines	 (Cerqueira	 et	 al.,	
2002).	 The	 presence	 and	 size	 of	 infarction	 and	 MVO	 were	 measured	 from	 LGE	
images.	Infarcted	myocardium	was	defined	as	an	area	of	LGE	≥2	standard	deviations	
(SD)	 above	 remote	 myocardium,	 and	 infarct	 volume	 estimation	 included	 any	
hypointense	core.	We	used	the	2SD	method	as	there	are	prognostic	data	for	the	2SD	
infarct	size	estimation	in	similar	populations	(Kwon	et	al.,	2014),	and	for	consistency	
with	 analysis	 of	 T2w	 images.	MVO	was	 defined	 visually	 as	 the	 hypointense	 core	
within	the	infarcted	zone	and	planimetered	manually.	Volumes	of	infarct	and	MVO	
were	calculated	from	planimetered	areas	through	the	whole	short-axis	LV	LGE	stack	



















cines	 (4-chamber	 and	 2	 chamber).	 Endocardial	 borders,	 epicardial	 borders	 and	
reference	 points	 at	 both	 RV	 insertion	 points	 (anterior/inferior)	 were	 contoured	
manually	for	each	slice	at	end-diastole	from	the	short	axis	LV	cine	stack.	GLS	and	
GLSR	were	derived	from	the	long-axis	images	and	GRS,	GRSR,	GCS	and	GCSR	were	
























Two	 case	 studies	 with	 STEMI:	 Case	 1	 (A	 to	 D):	 Anterior	 MI	 without	 MVO.	 (A)	
Epicardial	 (green)	 and	 endocardial	 (red)	 contours	 on	 a	 4-chamber	 cine.	 (B)	 Voxel	
derived	 feature	 tracking	 (FT)	 of	 the	 myocardium	 at	 end-systole.	 (C)	 Global	
longitudinal	 strain	 (GLS)	 curve	 demonstrating	 a	 GLS	 of	 -16.5%	 (D)	 LGE	 short-axis	
demonstrating	infarct	in	anterior	wall.	Case	2	(E	to	H):	(E)	demonstrates	the	contours	
and	(F)	shows	the	end-systolic	FT-derived	strain	myocardial	points	in	a	case	of	lateral	















Step-wise	multivariate	 linear	 regression	was	 used	 for	 parameters	with	 statistical	
significance	from	one-way	analysis	(p<0.1).	The	accuracy	of	myocardial	deformation	
parameters	 in	predicting	presence	of	MVO	or	 IMH	was	examined	using	 receiver-
operator	 characteristic	 (ROC)	 curve	 analyses,	 using	 Medcalc	 (v15.8).	 To	 reduce	
transfer	 bias,	 baseline	 demographics	 and	 CMR	 parameters	 of	 the	 followed-up	
patients	were	compared	to	patients	who	did	not	receive	follow-up	CMR	by	ANOVA.				
4.4 Results	















































































































































































Ejection	fraction,%	 48	±	10	 63	±	4	 <0.001	
LV	EDVi*,	ml/m2	 82	±	16	 78	±	20	 0.47	
LV	ESVi†,	ml/m2	 42	±	12	 28	±	8	 <0.001	
LV	stroke	volume	indexed,	ml	 40	±	11	 49	±	12	 0.023	
LGE	infarct	volume,	ml	 15	±	12	 NA	 NA	
LGE	MVO	volume,	ml	 3	±	5	 NA	 NA	
GRS,	%	 25	±	8	 38	±	7	 <0.001	
GRSR,	%/sec	 164	±	50	 268	±	125	 <0.001	
GCS,	%	 -13	±	4	 -20	±	2	 <0.001	
GCSR,	%/sec	 -106	±	132	 -107	±	12	 0.99	
GLS,	%	 -13	±	4	 -20	±	2	 <0.001	
GLSR	%/sec	 -128	±	314	 -88	±	13	 0.68	
	









GRSR	 were	 significantly	 altered	 in	 infarct	 patients	 versus	 healthy	 volunteers	
(p<0.001	for	all	parameters	individually)	(Table	4.2).		









-11.6±3%	 versus	 -15.6±3%,	 p<0.001;	 GLS:	 -11±3%	 versus	 -15.2±3.3%,	 p<0.001)	
(Figure	4.3).	




(r=	 0.57,	 P<0.001	 versus	 r=	 0.46,	 P=0.002)	 (Table	 4.4).	 The	 area	 under	 the	 curve	
(AUC)	for	the	diagnostic	performance	of	determining	the	presence	of	MVO	or	IMH	































Age	 0.07	 0.62	 	 	
Sex	 0.13	 0.38	 	 	
Smoking		 0.06	 0.70	 	 	
Hypertension	 0.07	 0.67	 	 	
Hypercholesterolemia	 0.05	 0.77	 	 	
Diabetes	Mellitus	 0.21	 0.19	 	 	










LVEDVi	 0.09	 0.57	 	 	
LVESVi	 0.38	 0.01*	 0.17	 0.26	
EF	 -0.50	 0.001*	 -0.27	 0.13	
GRS	 -0.39	 0.01*	 -0.07	 0.67	
Infarct	size	 0.50	 0.001*	 0.36	 0.01*	
GCS	 0.52	 <0.001*	 0.29	 0.16	
GLS	 0.53	 <0.001*	 0.53	 <0.001**	
GRSR	 -0.24	 0.122	 	 	
GCSR	 -0.12	 0.44	 	 	
GLSR	 0.18	 0.26	 	 	
Abbreviations:	 EF;	 ejection	 fraction,	 LVEDVi;	 left	 ventricular	 end-diastolic	 volume	





















	 r	 P-value	 r	 P-value	 r	 P-value	
EF	 0.29	 0.06	 -0.37	 0.01	 -0.37	 0.02	
LVEDVI	 -0.18	 0.24	 0.20	 0.20	 0.08	 0.60	
LVESVI	 -0.24	 0.12	 0.41	 0.01	 0.30	 0.05	
SVI	 0.03	 0.87	 -0.19	 0.23	 -0.24	 0.13	
GRS	 0.19	 0.21	 -0.32	 0.03	 -0.39	 0.01	
GRSR	 0.04	 0.79	 -0.24	 0.13	 -0.13	 0.41	
GCS	 -0.18	 0.25	 0.54	 <0.001	 0.57	 <0.001	
GCSR	 0.21	 0.18	 -0.01	 0.94	 -0.30	 0.06	
GLS	 -0.33	 0.03	 0.34	 0.02	 0.46	 0.002	


















suitable	 for	 FT	 analysis.	 Demographics	 parameters	 (age,	 gender,	 hypertension,	
hypercholesterolaemia,	 smoking	 history,	 diabetes	 mellitus)	 and	 baseline	 CMR	
parameters	 (presence	of	MVO	or	 IMH,	 LVEDVi,	 LVESVi	 and	all	 strain	parameters)	
were	not	significantly	different	in	the	9	patients	who	did	not	attend	for	follow-up	
scans	compared	with	the	overall	study	population	(p>0.1).	 	All	34	follow	up	scans	
showed	complete	 resolution	of	MVO	and	 IMH.	As	compared	 to	baseline,	 relative	
improvement	 in	 EF	was	 19±24.5%.	 Of	 all	 the	 baseline	 CMR	 parameters	 (LVEDVi,	
LVESVi,	 GLS,	 GCS,	 GRS,	 MVO,	 IMH),	 LVESVi	 (r=0.99,	 p<0.002)	 and	 GLS	 (r=0.97,	
p<0.006)	demonstrated	the	strongest	correlation	with	improvement	in	EF	at	follow-























Abbreviations:	 AUC;	 area	 under	 the	 curve,	 CI;	 confidence	 interval,	 EF;	 ejection	
fraction,	GCS;	peak	global	circumferential	strain,	GCSR;	peak	global	circumferential	
strain	rate,	GLS;	peak	global	longitudinal	strain,	GLSR;	peak	global	longitudinal	strain	
rate,	 GRS;	 peak	 global	 radial	 strain,	 GRSR;	 peak	 global	 radial	 strain	 rate,	 LV;	 left	
ventricle,	 LVEDVI;	 left	 ventricular	 end-diastolic	 volume	 indexed,	 LVESVI;	 left	
ventricular	end-systolic	volume	indexed;	r,	Pearson	correlation	coefficient.	
	


















et	 al.,	 2013).	 They	 demonstrated	 that	 regional	 functional	 recovery	 is	 poor	 in	
myocardial	 segments	 with	 MVO	 and	 IMH.	 Wong	 et	 al	 demonstrated	 that	
circumferential	strain	(CS)	using	tissue	tagging	correlates	better	than	circumferential	
strain	rate	with	regional	functional	recovery	(D.T.L.	Wong	et	al.,	2014).	Both	of	these	
studies	 used	 tissue	 tagging,	 which	 has	 a	 relatively	 low	 temporal	 resolution	 (<30	
frames/s),	potentially	limiting	its	accuracy,	especially	in	patients	with	higher	heart	
rates.	Moreover,	acquisition	of	 tissue	tagged	 images	often	requires	 long	series	of	
breath	 holds,	 and	 tag	 fading	 during	 diastole	 limits	 the	 assessment	 of	myocardial	
relaxation.	FT	analysis	of	cine	loops	may	overcome	these	limitations.	A	study	by	Khan	
et	 al	 compared	 tissue	 tagging	 to	 FT-derived	 strain	 in	 24	 acute	 reperfused	 STEMI	
patients.	FT-derived	strain	was	quicker	to	analyse,	tracked	the	myocardium	better,	


























These	 results	 are	 not	 unexpected	 as	 larger	 infarcts	 with	MVO	will	 involve	more	
myocardium	transmurally.		
4.5.1 Role	of	Echocardiography		
It	 is	 acknowledged	 that	 strain	 examination	 is	 more	 readily	 available	 by	
echocardiography	 than	 CMR.	 All	 modern	 echocardiographic	 systems	 come	 with	




GLS	assessment	may	be	used	as	a	 ‘gatekeeper’	 for	 further	advanced	 imaging,	 for	
example,	 multi-parametric	 tissue	 characterization	 on	 CMR.	 Further	 studies	 are	
needed	 to	 explore	 how	 echocardiography	 derived	 strain	 parameters	 compare	 to	
CMR-FT	derived	strain.		
4.5.2 MAPSE	or	FT	–	which	one	to	use?		












Our	 findings	 have	 possible	 clinical	 implications	 as	 FT-strain	 analysis	 can	 be	
performed	rapidly	from	standard	cine	CMR	images	and	allows	the	detection	of	the	
functional	 effects	 of	MVO	 and	 IMH	without	 the	 need	 for	 additional	 CMR	 tissue	
characterisation	techniques	(T2W	and	T2*)	and	analysis	methods.	From	our	single-




independent	histopathological	 and	 cardiac	 imaging	markers	of	 adverse	prognosis	
and	we	speculate	that	their	early	detection	from	routinely	acquired	CMR	cines	may	


















hence	 the	 demonstrated	 diagnostic	 performance	 of	 GLS	 to	 predict	 remodelling	
should	be	interpreted	with	caution.	Females	were	more	represented	in	the	HVs.	
In	the	present	study,	only	global	parameters	of	strain	were	investigated.	Assessment	





IMH	 and	 could	 be	 used	 as	 surrogate	 functional	 imaging	 marker	 of	 these	 acute	
myocardial	 pathological	 changes	 in	 patients	 with	 acute	 STEMI.	 Baseline	 GLS	







5 Study	 3-	 Effects	 of	 hyperaemia	 on	 left	 ventricular	













inclusion	 criteria	 and	 underwent	 CMR	 imaging.	 The	 CMR	 protocol	 included:	
rest/stress	4-chamber	cine,	rest/stress	first	pass	adenosine	perfusion	imaging	and	
late	gadolinium	enhancement	imaging.	Rest	and	stress	4-chamber	cine	CMR	images	













1.78,	 P-value<0.001).	 A	 threshold	 of	 -19.8%	 for	 stress	 GLS	 demonstrated	 78%	














during	 pharmacologically	 induced	 myocardial	 hyperaemia	 (Wolff	 et	 al.,	 2004).	
Although	 hyperaemic	 stress	 does	 not	 usually	 induce	 myocardial	 ischaemia,	
myocardium	 supplied	 by	 a	 significantly	 stenosed	 coronary	 artery	 shows	 reduced	
contrast	 uptake	 compared	 to	 normal	 myocardium.	 Hyperaemia	 also	 leads	 to	 a	
redistribution	 of	 myocardial	 blood	 flow	 (MBF)	 between	 the	 endocardial	 and	
epicardial	 layers	 (Pan	 et	 al.,	 2015),	 contributing	 to	 the	 detection	 of	 functionally	
significant	CAD	by	imaging	tests	with	sufficient	spatial	resolution	to	differentiate	the	
myocardial	 layers.	 An	 endo-	 to	 epicardial	 gradient	 of	 blood	 flow	 exists	 at	 rest,	
reflecting	 the	 higher	metabolic	 activity	 of	 the	 endocardial	 layer	 (Muehling	 et	 al.,	
2004;	 Radjenovic	 et	 al.,	 2010).	 In	 health,	 pharmacologically	 induced	 maximal	
hyperaemia	increases	MBF	in	all	myocardial	layers	although	the	endo	to	epicardial	
gradient	 diminishes	 as	MBF	maximizes	 in	 all	myocardial	 layers.	 In	 the	 context	 of	
functionally	significant	epicardial	CAD,	hyperaemia	leads	to	a	redistribution	of	MBF	










Figure	 5.1	 Illustration	 demonstrating	 how	 fiber	 orientation	 of	 the	 left	 ventricle	















(Panaich	 et	 al.,	 2016).	Myocardial	 deformation	 can	 be	 studied	with	 CMR	 feature	
tracking	(FT),	 in	which	strain	is	derived	from	routine	cine	acquisitions	without	the	
















1.	 Stress	 perfusion	 imaging:	 This	 was	 performed	 with	 adenosine	 administered	
initially	at	140	μg	kg−1	min−1.	Adequate	hemodynamic	response	was	assessed	by	
either	≥10%	heart	rate	increase	or	≥10	mm	Hg	decrease	in	systolic	blood	pressure.	
If	 there	 was	 an	 inadequate	 hemodynamic	 response,	 the	 dose	 was	 increased	





minutes	 until	 hemodynamic	 response	was	 achieved.	 Perfusion	 image	 acquisition	
used	 a	 2-dimensional,	 T1-weighted	 saturation	 recovery–prepared	 gradient	 echo-
pulse	sequence	in	3	short-axis	slices,	planned	using	the	3/5	technique,	using	parallel	
imaging	acceleration	(SENSE)	(Messroghli	et	al.,	2005).	A	bolus	intravenous	injection	













software	 (cvi42	 v5.1,	 Circle	 Cardiovascular	 Imaging	 Inc.,	 Calgary,	 Canada).	 Infarct	








adenosine	 infusion.	 Peak	 GLS	 (peak	 LV	 shortening	 during	 systole),	 GLSR	 (LV	


























acquisition	 at	 peak	 stress.	 Panel	 B	 demonstrates	 the	 derived	myocardial	 feature	
tracking	and	computed	systolic	GLS	at	peak	stress.	Panel	C	shows	the	corresponding	


















LGE	 images.	 In	 case	 of	 disagreement	 between	 the	 two	 observers,	 a	 third	
independent	expert	analysed	the	images,	and	a	discussion	of	the	study	commenced	
in	order	to	reach	a	unanimous	decision	(PG).	Studies	in	which	a	unanimous	decision	
could	 not	 be	 reached	 were	 excluded.	 On	 stress	 perfusion	 imaging,	 an	 area	 of	
decreased	signal	intensity	when	compared	to	remote	myocardium	and	the	presence	




perfusion	 defect	 was	 examined	 using	 the	 receiver-operator	 characteristic	 (ROC)	
curve	 analyses	 described	 by	 Delong	 for	 comparison	 of	 the	 area	 under	 the	 curve	
(AUC),	using	Medcalc	(v15.8).	Forward	(conditional)	multivariable	logistic	regression	
was	used	for	all	strain	parameters	with	statistical	significance	from	one-way	analysis	










A	 total	of	50	patients	were	 recruited.	4	patients	had	equivocal	perfusion	 results,	
resulting	in	exclusion	from	the	study	and	2	patients	were	claustrophobic.	From	the	




















Demographics	 (n=44)	 (n=22)	 (n=22)	 	
Age	(years)	 64±12	 64±12	 63±13	 0.53	
Gender	(male/female)	 31/13	 16/6	 15/7	 0.75	
Current	smoker	[no.	(%)]	 13	(30)	 7	(16)	 6	(14)	 0.75	
Hypertension	[no.	(%)]	 13	(30)	 7	(16)	 6	(14)	 0.75	
Diabetes	Mellitus	[no.	(%)]	 12	(27)	 6	(14)	 7	(16)	 0.45	
Dyslipidaemia	[no.	(%)]	 7	(16)	 3	(7)	 4	(9)	 0.69	
Myocardial	 Infarction	 [no.	
(%)]	
17	(39)	 10	(23)	 6	(14)	 0.22	
CABG	[no.	(%)]	 6	(14)	 4	(9)	 1	(2)	 0.13	
Abnormal	ECG	[no.	(%)]	 13	(30)	 8	(18)	 5	(11)	 0.33	
Baseline	CMR	parameters	 	 	 	 	
LV	EDV,	(ml/m2)	 143	±45	 151±46	 133±43	 0.19	
LV	ESV,	(ml/m2)	 55±32	 63±39	 45±21	 0.06	
LV	SV,	(ml/m2)	 86±29	 87.6±18	 84.4±37	 0.72	
LV	EF,	(%)	 64±13	 61±13	 67±12	 0.07	
LV	Mass	(grams)	 111±35	 112±26	 109±43	 0.76	
Presence	of	Infarction	(%)	 25	(57%)	 15	(34%)	 10	(23%)	 0.13	
Rest	strain	parameters	
GLS	(%)	 -18±4	 -16.9±3.7	 -19.6±3.4	 0.02	
GLSR	(s-1)	 -98±11	 -86±22	 -109±38	 0.02	
E’	(s-1)	 80±39	 69±31	 93±38	 0.04	











E’	(s-1)	 97±41	 90±50	 106±32	 0.21	



















































Rest	 LGE	-ve	 GLS	(%)	 -19±5	 -20±3	 0.59	
GLSR	(s-1)	 -101±19	 -119±53	 0.41	
E’	(s-1)	 94±32	 102±52	 0.69	
A’	(s-1)	 93±15	 97±36	 0.75	
LGE	+ve	 GLS	(%)	 -16±3	 -19±4	 0.04	
GLSR	(s-1)	 -78±20	 -99±13	 0.01	
E’	(s-1)	 56±21	 81±30	 0.02	
A’	(s-1)	 66±24	 74±25	 0.45	
Stress	 LGE	-ve	 GLS	(%)	 -18±4	 -22±3	 0.02	
GLSR	(s-1)	 -136±55	 -102±77	 0.32	
E’	(s-1)	 128±62	 111±24	 0.39	
A’	(s-1)	 113±46	 113±69	 0.99	
LGE	+ve	 GLS	(%)	 -16±4	 -20±3	 0.01	
GLSR	(s-1)	 -80±27	 -125±27	 <0.001	
E’	(s-1)	 72±32	 101±40	 0.06	












































GLS	(%)	 >-18.55	 77.27	 68.18	 0.72	 0.56	 0.87	 0.006	
GLSR	(s-1)	 >-91.09	 68.18	 72.73	 0.75	 0.60	 0.89	 0.0008	
E’	(s-1)	 ≤84.53	 86.36	 54.55	 0.70	 0.54	 0.86	 0.01	
A’	(s-1)	 ≤108.8
6	






GLS	(%)	 >-19.80	 77.3	 72.7	 0.82	 0.70	 0.94	 <0.001	
GLSR	(s-1)	 >-99.7	 63.6	 86.4	 0.74	 0.58	 0.89	 0.003	
E’	(s-1)	 ≤81.65	 50	 82	 0.67	 0.50	 0.83	 0.04	
A’	(s-1)	 ≤58.65	 36.36	 86.36	 0.58	 0.41	 0.76	 0.34	
	




SD	 or	 n	 (%)	 unless	 indicated.	 P-value	 <0.05	 was	 taken	 as	 significant.	


























	 	 OR	 95%	CI	 P-
value	
P-value	 P-value	
Rest	 GLS	 1.25	 1.03	-	1.52	 0.02	 0.74	 0.86	
GLSR	 1.04	 1.01	-	1.07	 0.02	 0.06	 0.77	
E’	 0.98	 0.96	-	1.00	 0.05	 0.32	 0.72	
A’	 0.99	 0.96	-	1.01	 0.18	 …	 …	
Stress	 GLS	 1.43	 1.14	-	1.78	 0.002	 <0.001		 0.68	
GLSR	 1.01	 0.99	-	1.02	 0.37	 …	 …	
E’	 0.99	 0.97	-	1.01	 0.21	 …	 …	
A’	 0.99	 0.98	-	1.00	 0.22	 …	 …	
Strain	
Model@	
	 	 	 <0.001	 …	 <0.0001	
	
Table	5.4		Predictors	of	perfusion	defect	in	univariable	(UV)	and	multivariable	(MV)	
logistic	 regression	analysis.	 P-value	<0.05	was	 taken	as	 significant.	 CI,	 confidence	




In	 the	 logistic	 regression	analysis,	 stress	GLS	demonstrated	 the	best	 independent	
association	with	the	presence	of	a	perfusion	defect	of	the	parameters	tested	(OR	
1.43	95%	CI	 1.14	 -	 1.78,	 P-value<0.001)	 (Table	 5.4).	 The	 logistic	 regression	 strain	









perfusion	 CMR	 2)	 among	 several	 strain	 parameters	 tested,	 stress	 GLS	 is	 most	
strongly	associated	with	the	presence	of	a	perfusion	defect	3)	a	cut-off	value	of	-
19.8%	 for	 stress	 GLS	 demonstrates	 77%	 sensitivity	 and	 73%	 specificity	 for	 the	
presence	of	a	perfusion	defect.	
Myocardial	ischaemia	initially	affects	the	endocardium	and	progresses	to	the	sub-
epicardial	 layers	 in	 a	 ‘wave	 front’	 manner.	 High	 resolution	 adenosine	 stress	
myocardial	 perfusion	 CMR	 can	 demonstrate	 a	 transmural	 gradient	 of	myocardial	
perfusion	 in	 patients	 with	 flow	 limiting	 CAD,	 representing	 the	 redistribution	 of	





affected	 during	 adenosine	 stress	 in	 patients	 with	 perfusion	 defects	 while	 GLS	 in	
patients	with	 no	 perfusion	 defects	 increased	 during	 hyperaemia.	 The	most	 likely	
mechanism	 underpinning	 this	 observation	 is	 that	 relative	 ischaemia	 of	 the	 sub-
endocardial	 myocardial	 layer	 (‘transmural	 myocardial	 steal’)	 affects	 longitudinal	
fibre	 function	 during	 hyperaemia	 and	 thus	 differentially	 reduces	 longitudinal	 LV	
function.		
In	patients	with	evidence	of	MI	on	LGE	 imaging,	 rest	GLS,	GLSR	and	E’	were	also	
correlated	 with	 the	 presence	 of	 perfusion	 defects,	 however	 these	 resting	 strain	
parameters	 did	 not	 discriminate	 between	 patients	 with	 and	 without	 perfusion	
defects	in	the	absence	of	previous	MI.	Like	ischaemia,	MI	predominantly	affects	the	
endocardial	layer	and	thus	longitudinal	myocardial	strain	and	a	reduction	in	resting	
myocardial	 deformation	 can	 therefore	 be	 expected.	 The	 correlation	 with	 the	
presence	of	an	inducible	perfusion	defect	is	likely	to	be	caused	by	co-existing	CAD	in	















GLSR	 in	 our	 study)	 and	 peak	 early	 diastolic	 strain	 rate	 (E’	 in	 our	 study)	 were	





5.2).	 A	 pre-clinical	 porcine	 study	 by	 Reant	 et	 al	 also	 demonstrated	 that	 flow	
reduction	 in	 the	 coronary	 artery	 achieved	 by	 adenosine	 induced	 myocardial	
hyperaemia	 (flow	 reduction	 by	 70%)	 adversely	 affected	 myocardial	 deformation	
parameters	(mainly	 longitudinal	and	circumferential	strain)	at	stress	(Reant	et	al.,	
2008).	 In	 a	 multi-centre	 study	 of	 102	 patients	 who	 underwent	 concomitant	
dobutamine	stress	echocardiography	and	coronary	angiography,	longitudinal	strain	
at	peak	stress	demonstrated	better	diagnostic	accuracy	than	wall	motion	score	(Ng	








with	 contraindications	 to	MR	 contrast	 agents	 such	 as	 those	with	 advanced	 renal	
failure.	Compared	with	dobutamine	stress	CMR,	adenosine	stress	has	a	lower	risk	
and	 imaging	 protocols	 are	much	 faster	 as	 only	 one	 stress	 stage	 is	 required.	 The	











practical	 and	 conceptual	 reasons	 we	 did	 not	 use	 coronary	 stenosis	 on	 invasive	
angiograpy	 as	 the	 primary	 end-point	 (Chow	 et	 al.,	 2009).	 Nevertheless,	
contemporary	CMR	sequences	for	first-pass	perfusion	defect	are	highly	accurate	in	
the	diagnosis	of	significant	ischaemia	(Greenwood	et	al.,	2012).	Thirdly,	the	present	
study	 did	 not	 evaluate	 regional	 myocardial	 function	 using	 standard	 quantitative	
methods	including	regional	and	global	wall	motion	scores.	Hence,	we	were	not	able	
to	compare	these	with	the	strain	parameters	obtained.	Fourthly,	our	results	need	to	
be	used	with	 caution	 in	 patients	with	 infiltrative	 cardiomyopathies	 (hypertrophic	
cardiomyopathy,	cardiac	amyloidosis,	sarcoidosis	etc.),	which	are	characterized	by	
stiffening	of	the	left	ventricle,	and	may	affect	myocardial	deformation	(Seward	and	
Casaclang-verzosa,	 2010).	 Several	 papers	 have	 demonstrated	 that	 the	




At	 peak	 myocardial	 hyperaemic	 stress,	 GLS	 is	 reduced	 in	 the	 presence	 of	 a	













to	 Quantify	 Myocardial	 Area	 at	 Risk	 and	 Chronic	


















P<0.0001;	 bias	 on	 Bland-Altman	 (BA)	 analysis	 0.18,	 95%	 CI	 -1.6-1.3).	 ECV	
demonstrated	the	best	linear	correlation	to	final	IS	at	a	threshold	of	>46%,	(R=0.92,	
95%	CI	0.86-0.95;	P<0.0001).	ECV-maps	demonstrated	better	agreement	with	final	

















Infarct	 size	 (IS)	 and	 myocardial	 salvage	 are	 important	 determinants	 of	 clinical	
outcome	 after	 myocardial	 infarction	 and	 are	 most	 accurately	 assessed	 with	
cardiovascular	magnetic	resonance	(CMR)(Schulz-Menger	et	al.,	2013).	The	size	and	
extent	 of	myocardial	 infarction	 on	 late	 gadolinium	 enhancement	 (LGE)	 CMR	 has	
prognostic	 value	 in	 the	 chronic	 setting	 (Di	 Bella	 et	 al.,	 2013).	 Recent	 literature	








thresholding	 is	 dependent	 on	 several	 factors	 including:	 1)	 windowing	 by	 the	
operator	to	decide	where	the	region	of	interest	(ROI)	is	placed,	2)	the	variation	of	






and	AAR	on	 an	 absolute	 scale	 (0%-100%).	 ECV	 has	 previously	 been	 shown	 to	 be	
increased	 in	 the	 AAR	 and	 infarcted	 myocardium	 (Ugander,	 Oki,	 et	 al.,	 2012;	
Jablonowski	et	al.,	2015;	Hammer-Hansen	et	al.,	2016),	but	thresholding	to	define	
cut-offs	of	ECV	to	quantify	AAR	and	IS	has	not	been	investigated.		













according	 to	current	best	practice	guidelines	 (Steg	et	al.,	2012).	TIMI	 flow	grades	




or	 3.0	 Tesla	 (Achieva	 TX,	 Philips,	 Best,	Netherlands)	within	72-hours	 (median	48-
hours)	of	their	index	presentation	and	were	invited	to	attend	for	a	further	CMR	study	
at	 3-months	 follow-up.	 A	 dedicated	 cardiac	 phased	 array	 receiver	 coil	 was	 used	
(1.5T:	24-channel;	3T:	32-channel).		
Cine,	T2W-imaging,	LGE-imaging	were	performed	using	a	contiguous	stack	of	short-
axis	 slices	 covering	 the	 whole	 left	 ventricle	 for	 each	 acquisition.	 The	 same	 slice	
geometry,	 position	 and	 10mm	 slice	 thickness	were	 used	 for	 all	 pulse	 sequences.	








Cine,	 T2W-images,	 and	 LGE-images	 were	 evaluated	 offline	 using	 Mass	 research	
















in	 the	selection	of	 the	 region	of	 interest	 (ROI),	ROI-contours	were	kept	 the	same	
between	 two	methods.	 	 For	 the	 FWHM,	 infarct	 core	 ROI	 was	 added	 as	 per	 the	

























































by	 T2W-imaging	 (applying	 FWHM	 thresholding),	 native	 T1-maps	 (applying	 2SD	
thresholding)	 and	 ECV-maps	 (applying	 greater	 than	 33%	 threshold).	 The	 AAR	
quantified	 by	 all	 three	 methods	 is	 comparable.	 IS	 quantification	 (Panel	 B):	







scanned	 at	 3-months	 at	 the	 same	 field	 strength	 as	 the	 baseline	 scan.	 IS	 was	
estimated	 using	 the	most	 validated	method	 to	 estimate	 chronic	 infarct	 size:	 the	
FWHM	 method(Flett	 et	 al.,	 2011).	 Segmental	 infarction	 using	 a	 16-segment	
model(Cerqueira	et	al.,	2002)	was	assessed	from	LGE	images	and	a	greater	than	75%	




Agreement	 between	 the	 different	 tests	 for	 IS	 and	 AAR	 are	 expressed	 as	 bias	
according	to	Bland-Altman	analysis.	For	paired	comparison	of	the	IS,	non-parametric	
Wilcoxon	 test	 (paired	 samples)	was	 used.	 Univariate	 analysis	was	 performed	 for	
















































Age,	yrs	 59±11	 61±12	 57±11	 0.27	
Male	 42	 26	 16	 0.49	
BMI,	kg/m2		 28±4	 28±4	 28±3	 0.44	
Smoker	 30	 18	 12	 0.48	
Hypertension	 8	 6	 2	 0.49	
Hyperlipidaemia	 17	 10	 7	 0.59	
Diabetes	Mellitus	 6	 4	 2	 0.89	
Family	 History	 of	
Coronary	Heart	Disease	
21	 14	 7	 0.74	
	 	 	 	 	
Presenting	
Characteristics	
	 	 	 	
Systolic	Blood	Pressure,	
mmHg	
135±31	 138±35	 130±21	 0.41	
Heart	rate,	beats/min	 73±15	 76±14	 68±14	 0.06	
Time	 from	 onset	 of	 CP	
to	reperfusion,	min	
228(155-392)	 234(144-383)	 222(185-407)	 0.68	
Heart	 Failure	 Killip	
Class✝	
	 	 	 	
I	 46	 30	 16	 0.55	
II	 3	 2	 1	 0.92	
III	or	IV	 1	 0	 1	 0.19	
Ventricular	 fibrillation	
at	presentation	
3	 2	 1	 0.92	
	 	 	 	 	
Angiographic	
Characteristics	







	 	 	 	
1	 31	 18	 13	 0.27	
2	 10	 8	 2	 0.25	
3	 8	 5	 3	 0.93	
Left	Main	Stem	 1	 1	 0	 0.46	
Culprit	Vessel	 	 	 	 	
Left	 anterior	
descending	
29	 21	 8	 0.15	
Left	circumflex	 4	 3	 1	 0.64	
Right	coronary		 17	 8	 9	 0.08	
TIMI	coronary	flow	pre-
PCI	
	 	 	 	
0-1	 44	 28	 16	 0.59	
2-3	 6	 4	 2	 	
TIMI	 coronary	 flow	
post-PCI	
	 	 	 	
0-1	 1	 1	 0	 0.29	
2-3	 49	 31	 18	 	
	 	 	 	 	
Laboratory	results		 	 	 	 	
Haemoglobin,	
grams/litre	
146(136-151)	 144(135-150)	 149(142-155)	 0.15	
White	blood	cell,	
x109/litre		



















acute	 myocardial	 infarction:	 class	 I=no	 heart	 failure;	 class	 II=pulmonary	 rales	 or	
crepitations,	 a	 third	 heart	 sound,	 and	 elevated	 jugular	 venous	 pressure;	 class	
III=acute	pulmonary	edema;	and	class	IV=cardiogenic	shock.		
∅	 Multi-vessel	 coronary	 artery	 disease	 was	 defined	 according	 to	 the	 number	 of	
stenoses	of	at	least	50%	of	the	reference	vessel	diameter	by	visual	assessment	and	
whether	or	not	there	was	left	main	stem	involvement.		
Abbreviations:	 BMI,	 body	 mass	 index;	 CMR,	 cardiac	 magnetic	 resonance;	 ECV,	


































32	 38.7	 20.4	 37.6	 15.1	 -1.1	 7.2	 -6.2	to	4.0	 0.64	 12.8	 12.0%	 2.2	to	28.5	
33	 35.9	 19.7	 37.6	 15.1	 1.7	 6.8	 -3.2	to	6.5	 0.45*	 12.8*	 11.5%*	 3.8	to	28.5	








44	 15.8	 12.6	 12.9	 9.8	 -2.9	 4.0	 -5.7	to	-0.1	 0.05	 23.6	 30.4%	 20.7	to	74.4	
45	 14.7	 12.0	 12.9	 9.8	 -1.7	 3.8	 -4.4	to	0.9	 0.18	 20.4	 17.0%	 12.6	to	74.1	
46	 13.2	 11.2	 12.9	 9.8	 -0.2	 2.9	 -2.3	to	1.8	 0.80*	 15.0*	 10.1%*	 5.1	to	70.7	
47	 12.2	 10.4	 12.9	 9.8	 0.8	 2.5	 -1.0	to	2.5	 0.36	 14.0	 19.8%	 3.8	to	56.5	
48	 11.2	 9.8	 12.9	 9.8	 1.8	 2.3	 0.1	to	3.4	 0.04	 16.5	 25.5%	 8.1	to	41.5	
49	 10.1	 9.1	 12.9	 9.8	 2.9	 2.4	 1.1	to	4.6	 0.00	 22.6	 25.9%	 9.3	to	49.2	
50	 9.1	 8.5	 12.9	 9.8	 3.8	 2.7	 1.8	to	5.7	 0.00	 29.6	 34.6%	 9.4	to	56.7	
51	 8.2	 7.9	 12.9	 9.8	 4.8	 3.2	 2.6	to	7.0	 0.00	 37.8	 43.4%	 19.2	to	64.4	










0.98;	 P<0.0001).	 Additionally,	 the	 AAR	 estimated	 by	 T2W-imaging	 was	 not	
significantly	different	to	the	AAR	estimated	from	ECV-maps	at	a	threshold	of	33%	


















































compared	 to	 the	 acute	 IS	 by	 LGE-imaging	 (Bias=10,	 95%	 CI	 7.7-12.4).	 Acute	 IS	
estimated	by	the	5-standard	deviation	method	on	LGE-imaging	demonstrated	the	







LVEDVI,	ML/M2	 82±14.7	 79.4±22.6	 0.65	
LVESVI,	ML/M2	 45.5±14.5	 41.3±8.1	 0.27	
LVMI,	GRAMS	 59.4±13.8	 55.3±10.8	 0.27	
EJECTION	FRACTION,	%	 45±11.1	 44±7.6	 0.72	
LGE	IS	(FWHM),	VOLUME	IN	%	 28.8±15.7	 25.2±12.2	 0.41	
LGE	IS	(5SD),	VOLUME	IN	%	 28.1±17	 28.6±16.5	 0.92	
MVO	SIZE,	VOLUME	IN	%	 4.9±5.4	 2.3±3	 0.06	
AAR,	VOLUME	IN	%	 47.3±19.2	 47.5±16.2	 0.96	
ECV	>33%,	VOLUME	IN	%	 46.8±18.7	 47.9±15.5	 0.82	
ECV	>46%,	VOLUME	IN	%	 20.4±13.7	 17.6±13	 0.49	
BORDER-ZONE	ECV,	%	 38.2±2.3	 39.4±2.5	 0.11	
Table	6.3	Baseline	infarct	characteristics	at	1.5T	and	3T.	Values	are	mean	±	SD.	LV	





unindexed.	 LV	 EDVi	 Left	 ventricular	 end	 diastolic	 volume	 (indexed),	 LV	 ESVi	 Left	
ventricular	end	systolic	volume	(indexed),	LVM	left	ventricular	mass	(indexed).	
6.4.5 Per	segment	viability	characteristics	





































non-viable	 segments.	 Even	 though	 the	 trends	 for	both,	acute	ECV-maps	and	LGE-








Regression	 analysis	 is	 presented	 in	 Table	 6.4.	 On	multivariable	 linear	 regression	
analysis,	acute	IS	by	ECV-maps	was	independently	associated	with	follow-up	IS	(beta	
0.92;	P<0.0001)	and	not	acute	IS	by	LGE-imaging	(p=0.89).	Moreover,	the	number	of	










Variable	 UV	 MV	 UV	 MV	
Age	 0.53	 	 0.92	 	
Gender	 0.69	 	 0.24	 	
Current	Smoker	 0.03	 	 0.04	 0.50	
Hypertension	 0.98	 	 0.57	 	
Hypercholesterolemia	 0.69	 	 0.66	 	
Diabetes	 0.44	 	 0.53	 	
Family	history	of	CAD	 0.47	 	 0.15	 	
Systolic	BP	 0.29	 	 0.96	 	
Heart	Rate	 0.22	 	 0.76	 	
TIMI	flow	pre-PCI	 <0.01	 0.37	 0.12	 	
TIMI	flow	post-PCI	 0.96	 	 0.95	 	
Door	to	Balloon	time	 0.20	 	 0.53	 	
LVEDV	 0.01	 0.98	 0.74	 	
LVESV	 <0.01	 0.91	 0.04	 0.16	
LV	Mass	 0.16	 	 0.89	 	
Ejection	Fraction	 <0.01	 0.37	 <0.01	 0.68	
MVO	 <0.01	 0.71	 <0.01	 0.75	













The	present	 study	demonstrates	 that	acute	ECV-maps	offer	a	 robust	and	 reliable	














expansion,	 which	 is	 adversely	 related	 to	 mechanical,	 electrical	 and	 vasomotor	
dysfunction	(Moon	et	al.,	2013).	Hence,	ECV-maps	add	incremental	diagnostic	value	

































Figure	 6.5	 Short-axis	 illustration	 of	 the	 LV.	 This	 illustration	 demonstrates	 acute	
infarct	size	 is	overestimated	by	acute	LGE-imaging.	On	ECV-maps,	 it	 is	possible	 to	
differentiate	three	zones	in	the	territory	of	AMI:	the	AAR,	the	border-zone	(zone	with	
extensive	peri-infract	oedema	and	possible	islets	of	cell	injury,	which	recovers	over-


















the	 extracellular	 space	 and	 the	 contrast	 kinetics	 in	 the	 injured	myocardium	 and	
consequently	 contributes	 to	 the	 over-estimation	 of	 IS	 by	 LGE-imaging.	 Another	
pertinent	finding	was	that	the	ECV	of	the	infarcted	myocardium,	computed	using	the	
different	post-contrast	T1-maps	at	different	time	points,	ranging	from	5-20	minutes	
after	 the	 contrast	 injection,	 remained	 similar.	 This	may	explain	why	 ECV	 is	more	
reliable	to	quantify	the	IS	acutely	versus	the	LGE-imaging,	which	heavily	depends	on	
timing	of	the	acquisition	post-contrast	delivery.		













higher	 remote	 myocardial	 ECV	 on	 acute	 presentation	 were	 more	 likely	 to	 have	






core	 quantified	 by	 ECV-maps	 predicts	 functional	 recovery	 better	 than	 any	 other	














the	 bolus	method	 used	 in	 this	 study	 can	 be	more	 easily	 integrated	 into	 existing	
clinical	 protocols.	 The	 results	 from	present	 study	 cannot	 be	 applied	 in	 not-acute	
infarct	cases	and	non-ST	elevation	MI.		
6.6 Conclusion	
This	 study	demonstrates	 that	 ECV-maps	 in	patients	with	 acute	 reperfused	 STEMI	
permit	reliable	quantification	of	AAR	and	final	IS	at	follow-up.	Furthermore,	acute	IS	
by	ECV-maps	are	independently	associated	with	the	number	of	non-viable	infarcted	








7 Study	5–	 Comparison	of	Acceleration	Algorithms	 in	
Whole-Heart	 Four-Dimensional	 Flow	 for	




Validation	of	 four-dimensional	 (4D)	 flow	CMR	accelerated	 acquisition	methods	 is	
needed	to	make	 it	more	robust	 for	clinical	applications.	Our	aim	was	to	compare	
three	 widely-used	 acceleration	 methods	 in	 4D	 flow	 CMR:	 4D	 segmented	 fast-














for	4D-EPI	7.6±1.3%	and	 for	4D-k-t	BLAST	4.4±1.9%.	 In	vivo,	acquisition	 time	was	












were	 within	 reasonable	 limits	 for	 clinical	 applications.	 In	 vivo,	 4D-EPI	 had	 the	
shortest	 acquisition	 time,	 best	 agreement	 with	 2D	 PC,	 best	 internal	 consistency	
between	MV	and	AV	NFF	and	the	lowest	CV.	4D-k-t	BLAST	demonstrated	significant	








Four-dimensional	 flow	 cardiovascular	 magnetic	 resonance	 (4D	 flow	 CMR)	 is	
increasingly	being	used	in	clinical	and	research	applications	for	complex	aortic	and	
intra-cardiac	 flow	 assessment.	 4D	 flow	 CMR	 is	 essentially	 a	 three-dimensional	
phase-contrast	magnetic	resonance	imaging	(PC	MRI)	method	with	three-directional	







has	 been	 challenging	 in	 part	 due	 to	 long	 scan	 times	 (acquisition	 of	 3D	 velocity	
encoded	CMR	data	along	all	the	three	dimensions).	Scan	times	can	be	reduced	with	
numerous	 data	 acceleration	methods,	 including	 radial	 under-sampling,	 k-t	 Broad	
Linear	 Acquisition	 Speed-up	 Technique	 (BLAST)	 (Philips),	 k-t	 Sensitivity	 encoding	
(SENSE)	 (Philips),	 generalised	 auto-calibrating	 partially	 parallel	 acquisitions	
(GRAPPA)	 (Siemens),	 echo-planar	 imaging	 (EPI),	 Iterative	 self-consistent	 parallel	



























investigate	 clinical	 applications	 for	 this	 novel	 technique	 (Elbaz	 et	 al.,	 2014;	
Westenberg	et	al.,	2008).	
However,	head-to-head	validation	of	these	three	accelerated	algorithms	for	whole-
heart	 acquisition	 in	 clinical	 applications	 is	 needed	 for	 both	 clinical	 and	 research	









Static	 and	 pulsatile	 flow	 phantom	 experiments	 were	 carried	 out	 at	 the	 Leiden	
University	 Medical	 Center	 using	 48	 ml	 diluted	 gadolinium	 based	 contrast	 agent	










3M	 Sarns	 control	 module	 (3M	 Health	 care,	 Borken,	 Germany)	 (Figure	 7.1A).	
Approximately	3	meters	supplying	and	3	meter	returning	tube	was	required	to	led	
the	 flow	 in	 and	 out	 or	 the	MRI	 room.	 The	 tube	was	 placed	 inside	 a	water	 tank,	
submerged	under	static	water	and	positioned	in	the	iso-center	of	the	CMR	gantry.	
In	the	static	phantom	setup,	six	static	flows	ranging	from	2.52	l/min	to	6.50	l/min	




triggering	was	 realised	by	 an	external	 transistor-transistor-logic	 TTL	 trigger	 signal	
sent	 from	 the	 pump	 control	 unit	 to	 the	MRI	 computer.	 For	 each	 acquisition,	 30	
phases	were	reconstructed,	unless	the	required	amount	of	data	to	be	collected	did	
not	 allow	 reconstruction	 of	 this	 many	 phases	 without	 making	 changes	 to	 the	
















































mm	 (i.e.,	 isotropic	 data),	 but	 for	 2D	 PC,	 slice	 thickness	 was	 8	 mm.	 Other	 scan	





positioned	 in	 the	 center	 of	 the	 4D	 flow	 CMR	 volume	 (Figure	 7.1B).	 For	 all	
acquisitions,	only	through-plane	flow	velocity	was	analysed.		
Before	and	after	each	MRI	acquisition,	a	time-beaker	measurement	was	performed	





































was	 1.	 Free	 breathing	was	 allowed	 during	 acquisition	 and	 no	 respiratory	motion	
correction	was	used.	For	4D-TFE	and	4D-EPI	accelerated	techniques,	retrospective	
















background	 ROI	 (indicated	 by	 the	 yellow	 contour	 in	 Figure	 7.1C)	 enclosing	 the	








phantom	specifications	 (i.e.	 0.79	 cm2).	 This	ROI	was	manually	placed	on	 the	 first	
phase	of	a	time	series	and	copied	to	subsequent	phases.	For	all	phantom	4D	flow	
data	 sets,	 image	 analysis	 was	 performed	 for	 the	 three	 center	 slices	 and	
measurements	were	averaged	among	the	three	samples.	
For	each	4D	 flow	CMR	sequence,	quality	 checks	were	performed	by	 J.J.M.W.,	 an	
experienced	researcher	in	this	field	of	CMR	with	greater	than	15	years’	experience.	
Visual	 grading	 of	 image	 quality	 was	 done	 on	 a	 four-point	 scale:	 0;	 no	 artefacts	
present,	1;	good	quality	but	with	some	blurring	artefacts	on	magnitude	images	but	
none	 on	 velocity	 images,	 2;	 moderate	 quality	 with	 substantial	 blurring	 on	 both	
















To	 investigate	 linear	 correlation	 between	 two	 methods,	 Pearson's	 correlation	





The	 mean	 error	 in	 flow	 volume	 assessment	 (compared	 to	 time	 beaker	
measurements)	 for	 the	 2D	 PC	 sequence	 was	 -0.8±1.2%	 (p=0.22)	 for	 the	 static	
experiments	 and	 -1.0±1.1%	 (p=0.001)	 for	 the	 pulsatile	 experiments.	 For	 static	
experiments,	 the	 mean	 error	 for	 4D-TFE	 was	 -5.2±1.1%	 (p=0.003),	 for	 4D-EPI	 -
7.1±1.9%	 (p=0.001)	 and	 for	 4D-k-t	 BLAST	 -4.9±3.8%	 (p=0.03).	 For	 the	 pulsatile	
experiments,	 the	 mean	 error	 for	 4D-TFE	 was	 -4.9±1.3%	 (p=0.002),	 for	 4D-EPI	 -
















	 All	(n=25)	 Leiden	(n=14)	 Leeds	(n=11)	 p-value	
Age,	years	 37.6±14.5	 38±14.7	 38.9±14.7	 0.61	
Male	 17(68%)	 10	(71%)	 7	(64%)	 0.69	
Weight,	kg	 76±13	 76.6±14	 75.5±12	 0.83	
Height,	cm	 171±8	 173±7	 169±8	 0.15	
Heart	rate,	bpm	 63±9	 63±10	 63±9	 0.94	
	 	 	 	 	
LVEDVi*,	ml/m2	 90.4±16.6	 90.4±2	 90.5±12.3	 1	
LVESVi†,	ml/m2	 34.4±11	 35.2±13.4	 33.3±7.5	 0.66	
SVi,	ml/m2	 56±8	 55±8	 57±8	 0.55	
LV	Massi,	g	 53.6±10.5	 54±12	 53±9	 0.88	










0.6±1	(9)	 0.9	(7)	 1.1	(2)	 0.20	



























































acquisition	 method	 (r=0.78,	 p<0.001).	 4D-TFE	 and	 4D-k-t	 BLAST	 demonstrated	
modest	 correlation	 to	 2D	 PC	 acquisition	 (4D-TFE:	 r=0.56,	 p=0.04;	 4D-k-t	 BLAST:	
r=0.59,	p=0.002)	(Table	7.3).		
	
Peak	 velocity	 assessment	 for	 both	 MV	 and	 AV	 by	 4D-EPI	 demonstrated	 best	























































2D	PC	AV	 127.6	 19.6	 …	 …	 …	 …	
2D	PC	MV	 81.7	 17.2	 …	 …	 …	 …	
4D-TFE	AV	 151.7	 23.9	 0.56,	p=0.04	 -22	
(-31	to	12)	
<0.001	 21.4	
4D-TFE	MV	 98.2	 35.2	 0.59,	p=0.01	
4D-EPI	AV	 130.7	 22.1	 0.78,	p<0.001	 -2	
(-7	to	2)	
0.21	 9.8	
4D-EPI	MV	 83.8	 22.0	 0.71,	p<0.001	
















Net	 forward	 flow	 (NFF)	 (or	 effective	 stroke	 volume)	 through	 the	 MV	 and	 AV	




















2D	Phase	Contrast	 	 	 	 	
E,	cm/s	 81.7	 17.2	 …	 …	
A,	cm/s	 48.8	 9.6	 …	 …	
E	volume,	ml	 77.8	 17.8	 …	 …	
A	volume,	ml	 25.00	 6.7	 …	 …	
E/A	 1.8	 0.6	 …	 …	
PEFR,	ml/s	 602.7	 150.9	 …	 …	
PLFR,	ml/s	 300.8	 77.2	 …	 …	
4D-TFE	 	 	 	 	
E,	cm/sec	 112.3	 26.4	 0.000	 <0.001	
A,	cm/sec	 69.4	 24.4	 0.003	 <0.001	
E	volume,	ml	 67.8	 16.9	 0.004	 0.549	
A	volume,	ml	 22.3	 6.5	 0.051	 0.321	
E/A	 1.8	 0.5	 0.725	 0.052	
PEFR,	ml/s	 494.7	 127.1	 0.000	 0.368	
PLFR,	mL/s	 277.5	 71.5	 0.148	 0.253	
4D-EPI	 	 	 	 	
E,	cm/s	 90.0	 21.4	 0.035	 …	
A,	cm/s	 48.4	 11.8	 0.861	 …	
E	volume,	ml	 69.7	 15.3	 0.012	 …	
A	volume,	ml	 21.9	 6.3	 0.012	 …	
E/A	 1.9	 0.6	 0.057	 …	
PEFR,	ml/sec	 508.1	 99.5	 0.001	 …	
PLFR,	ml/sec	 269.6	 80.5	 0.043	 …	
4D-k-t	BLAST	 	 	 	 	
E,	cm/s	 73.1	 13.2	 0.041	 <0.001	
E	volume,	ml	 66.6	 17.4	 0.007	 0.366	
PEFR,	ml/s	 414.6	 116.6	 <0.001	 <0.001	
Table	7.4	Diastolic	flow	assessment	using	all	acceleration	methods.		




























The	 present	 study,	 involving	 in	 vitro	 and	 in	 vivo	 experiments	 to	 investigate	
robustness,	accuracy	and	applicability	of	accelerated	methods	of	4D	flow	CMR	for	
whole-heart	imaging	and	valvular	flow	assessment	demonstrated	the	following:	1)	
When	 comparing	 three	 previously	 used	 acceleration	 methods	 for	 4D	 flow	 CMR	
acquisition,	 4D-EPI	 requires	 the	 shortest	 acquisition	 time	 versus	 segmented	 fast-
gradient	echo	(TFE)	and	k-t	BLAST	acceleration,	and	4D-EPI	results	in	adequate	image	
quality	for	analysis.	2)	In	phantoms,	4D-EPI	showed	the	largest	error	in	in-vitro	flow	




flow	 and	 mitral	 valve	 net	 forward	 flow	 and	 therefore,	 showed	 highest	 internal	
consistency.	
4D	flow	CMR	has	evolved	in	recent	years	as	a	clinical	application	for	evaluating	intra-
cardiac	 flow.	 The	 use	 of	 modern	 data	 acceleration	 methods	 to	 speed	 up	 data	
acquisition	in	particular	has	allowed	a	wider	application	of	this	technique	in	clinical	
research	 studies.	 Several	 studies	 have	 investigated	 accelerated	methods	 for	 flow	






scan	 parameters	 (FOV,	 spatio-temporal	 resolution	 etc.)	 and	 not	 necessarily	 with	
intra-cardiac	 assessment	 for	 quality	 and	 consistency	 of	 flow.	 Vender-specific	













recently	 published	 recommends	 the	 use	 of	 segmented	 fast-gradient	 echo	 (TFE)	
methods	combined	with	2-fold	parallel	imaging	(SENSE)	(Dyverfeldt	et	al.,	2015).	We	
compared	this	approach	with	two	other	acceleration	techniques,	EPI	and	k-t	BLAST,	
which	 have	 also	 been	widely	 used	 in	 clinical	 research	 studies.	 In	 vitro	 validation	
showed	 that	 2D	 PC	was	 very	 accurate	 with	 respect	 to	 flow	 volume	 assessment,	
presenting	 an	 error	 of	 1%.	 All	 4D	 flow	 CMR	 assessments	 showed	 a	 significant	
underestimation	 of	 flow	 volume,	 with	 EPI	 presenting	 the	 highest	 error	 (7%)	
compared	 to	 TFE	 and	 k-t	 BLAST	 (5%).	 These	 errors,	 while	 being	 statistically	
significant,	are	all	within	clinically	acceptable	margins	of	less	than	10%.	














time	 blurring	 issues	with	 prospective	 gating	 (Carlsson	 et	 al.,	 2011).	 Zaman	 et	 al.	
demonstrated	 that	 using	 contemporary	 coil	 systems,	 this	 can	 be	 mitigated	 and	
reliable	peak	velocity	and	stroke	volume	assessment	can	be	made	using	respiratory	






that	 4D-k-t	 BLAST	demonstrated	underestimation	of	 flow	 in-vivo	 (Carlsson	 et	 al.,	
2011).	Zaman	et	al.	used	respiratory	navigation	for	all	their	accelerated	algorithms,	





and	 multi-parametric	 4D	 flow	 assessments.	 It	 would	 be	 plausible	 to	 imply	 that	
without	 respiratory	navigation;	4D-k-t	BLAST	 is	not	 suitable	 for	 intra-cardiac	 flow	
quantification.		
Prospectively	 ECG-triggered	 GRAPPA	 and	 more	 advanced	 kt-GRAPPA	 have	 been	






4D	 flow	 MRI	 can	 be	 sped	 up	 without	 the	 use	 of	 accelerated	 algorithms	 using	
respiratory	navigated	spiral	trajectories	(Petersson	et	al.,	2016).	This	method	does	
not	 compromise	 in	 spatio-temporal	 windows	 and	 demonstrates	 reliability	 and	
consistency	 for	 intracardiac	 flow	 quantification	 including	 diastolic	 inflow	 indices.	
However,	mean	scan	times	for	this	spiral	acquisition	in	their	study	were	higher	(13	±	
3	minutes)	than	the	most	reliable	accelerated	technique	in	the	present	study,	4D-
EPI	 (8	 ±	 2	 minutes),	 most	 likely	 because	 Petersson	 used	 respiratory	 navigation.	




The	 in-vitro	 validation	of	 the	 various	 2D	 and	4D	 flow	acquisition	 techniques	was	






complex	 intra-cardiac	 flow	patterns	 that	would	probably	give	more	 insight	 in	 the	
performance	 of	 the	 various	 CMR	 flow	 acquisition	 techniques	 under	 more	
physiological	conditions.	
In	this	study	all	healthy	volunteers	had	very	stable	resting	heart	rates	of	63±9	beats	
per	minute	 (bpm).	Additionally,	 the	present	study	did	not	 investigate	the	relative	
performance	 of	 the	 methods	 in	 the	 presence	 of	 minor	 arrhythmias	 (sinus	
arrhythmias,	isolated	ventricular	ectopics	etc.).	Additionally,	even	though	we	tried	
to	 keep	 all	 acquisitions	 parameters	 similar	 for	 the	 three	 4D	 flow	 methods,	
occasionally,	 one	method	would	 need	 slight	 adjustment	 of	 the	 field	 of	 view,	 the	
number	of	slices	or	phases.		
7.7 Conclusion	













that	 CMR	 can	 provide	 accurate	 quantification	 of	 LV	 longitudinal	 function	 and	








investigate	 and	 validate	 different	 acceleration	methods	 for	 4D	 flow	 CMR	whole-










iii. Myocardial	deformation	 imaging	by	CMR	reliably	detects	changes	 in	acute	
infarct	patients	versus	healthy	controls	








i. At	peak	myocardial	 hyperaemia	GLS	 is	 reduced	 in	patients	with	perfusion	
defects	on	simultaneously	acquired	first-pass	perfusion	CMR		




















iii. 4D-EPI	demonstrated	best	correlation	and	 least	bias	 for	 intra-cardiac	peak	
velocities	to	the	reference	method	of	2D	PC	acquisition		
iv. 4D-EPI	demonstrated	the	best	agreement	between	aortic	valve	net	forward	




























In	 this	 thesis,	 we	 have	 demonstrated	 that	 using	 semi-automated	 thresholding	
applied	to	ECV-maps	can	be	used	to	quantify	AAR	and	IS.	ECV	thresholds	of	33%	and	
46%	 proved	 to	 be	 accurate	 post-acute	 infarction	 for	 AAR	 and	 final	 infarct	 size.	
Furthermore,	there	is	a	growing	body	of	literature	that	ECV	maps	add	incremental	
diagnostic	benefit	in	acute	chest	pain	syndromes	(Haaf	et	al.,	2016).	In	this	thesis,	
we	only	 investigated	 functional	 recovery	as	 an	outcome	measure.	 Future	 studies	










Examining	 these	 intricate	 fluid	 dynamics	 has	 the	 potential	 to	 further	 our	
understanding	of	the	principles	of	cardiovascular	health	and	disease.		
In	this	thesis,	we	demonstrated	that	4D	flow	using	EPI	is	the	most	robust	and	reliable	
acceleration	 method	 for	 whole-heart	 flow	 assessment	 using	 a	 free-breathing	
sequence	 with	 scanning	 times	 of	 5-8	 minutes,	 suggesting	 potential	 for	 clinical	
application	in	both	stable	and	more	acute	scenarios.	Whole	heart	4D	flow	has	several	
advantages	 over	 echocardiography	 or	 even	 2D	 PC	 acquisitions.	 These	 primarily	
include:	both	right	and	left	ventricular	flow	can	be	investigated	for	‘same	averaged	
cardiac	 cycles’,	 using	 retrospective	 valve	 tracking,	 accurate	 stroke	 volume	 and	
regurgitation	 volumes	 can	 be	 computed	 and	 it	 allows	 for	 3D	 flow	 visualisation	
including	vortex	formation	within	cardiac	chambers.	While	this	thesis	demonstrated	
feasibility	 of	 the	method,	 larger,	 hypothesis	 driven	 clinical	 studies	 using	 4D	 flow	
parameters	against	standard	flow	parameters	are	warranted.		
We	speculate	that	4D	flow	derived	quantitative	flow	parameters	will	provide	very	
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